课题基金 / 基金详情

Bioengineered chimpanzee adenovirus-based vaccines against tuberculosis: Optimization of immunologic property, formulation and delivery for bench-to-human applications

Bioengineered chimpanzee adenovirus-based vaccines against tuberculosis: Optimization of immunologic property, formulation and delivery for bench-to-human applications
基于黑猩猩腺病毒的生物工程结核病疫苗:优化免疫特性、配方和交付以用于人体应用
批准号:
269861
负责人:
Xing Zhou
金额:
$35.46万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-10-01 至 2015-10-01

项目摘要

项目成果

Xing Zhou的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lung tuberculosis (TB) is one of the leading global infectious causes of death. TB still remains a serious health concern in Canada due to ever-increasing immigrant populations (latent TB), high incidence rates of TB in First Nations communities, and much
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 Variant Supplement - Rapid bench-to-human development of safe and effective aerosol vaccine strategies against Covid-19
  • 批准号:
    442864
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.64万
  • 财政年份:
    2021
  • 负责人:
    Xing Zhou
  • 依托单位:
Rapid bench-to-human development of safe and effective aerosol vaccine strategies against Covid-19
  • 批准号:
    430637
  • 项目类别:
    Operating Grants
  • 资助金额:
    $139.94万
  • 财政年份:
    2020
  • 负责人:
    Xing Zhou
  • 依托单位:
Respiratory mucosal immunity and novel vaccination strategies against pulmonary tuberculosis
  • 批准号:
    353762
  • 项目类别:
    Operating Grants
  • 资助金额:
    $179.41万
  • 财政年份:
    2016
  • 负责人:
    Xing Zhou
  • 依托单位:
Novel multivalent chimpanzee adenovirus-based vaccines against pulmonary tuberculosis
  • 批准号:
    343353
  • 项目类别:
    Operating Grants
  • 资助金额:
    $63.77万
  • 财政年份:
    2016
  • 负责人:
    Xing Zhou
  • 依托单位: